Integrating transdiagnostic and holistic approaches in early neurodevelopmental screening.
Kahoko Yasumitsu-Lovell
PMID 41319098WHAT IT FOUND
No new screening evidence is reported here.
The paper is a commentary on another study and reports no original methods or outcomes.
What this paper is
This is a commentary discussing a transdiagnostic neurodevelopmental screening study. It has no original methods or results, so there is no finding to act on.
The easy way to misread this
Do not read this as evidence that the MOS-R or HINE predicts cerebral palsy, autism, or fetal alcohol spectrum disorder. It is a commentary on another study and reports no original methods or results.
Summarised by AI from the full paper, without a clinician reviewing it. Check it against the source before it changes what you do. Read it on PubMed →